FDA safety warning on the cardiac effects of lamotrigine: An advisory from the Ad Hoc ILAE/AES Task Force

• Jacqueline A. French,
• Emilio Perucca,
• Josemir W. Sander,
• Lennart Bergfeldt,
• Michel Baulac,
• David S. Auerbach,
• Mark Keezer,
• Roland D. Thijs,
• Orrin Devinsky,
• David G. Vossler,
• Timothy E. Welty

Affiliations

Jacqueline A. French

Department of Neurology New York University Grossman School of Medicine and NYU Langone Health New York NY USA

Emilio Perucca

Department of Internal Medicine and Therapeutics University of Pavia Pavia Italy

Josemir W. Sander

UCL Queen Square Institute of Neurology London UK

Lennart Bergfeldt

Department of Molecular & Clinical Medicine Institute of Medicine Sahlgrenska Academy, University of Gothenburg Gothenburg Sweden

Michel Baulac

Department of Neurology, Salpetrière University Hospital & ICM Sorbonne Université Paris France

David S. Auerbach

Department of Pharmacology SUNY Upstate Medical University Syracuse NY USA

Mark Keezer

Stichting Epilepsie Instellingen Nederland (SEIN) Heemstede The Netherlands

Roland D. Thijs

UCL Queen Square Institute of Neurology London UK

Orrin Devinsky

Department of Neurology New York University Grossman School of Medicine and NYU Langone Health New York NY USA

David G. Vossler

University of Washington Seattle WA USA

Timothy E. Welty

College of Pharmacy and Health Sciences Drake University Des Moines IA USA